RASSF6 and colorectal carcinoma: Addtionally, we first established both hepatic and lung metastasis models to demonstrate that RASSF6 inhibits metastasis of CRC cell lines in vivo to further confirm the role of RASSF6 in CRC (Figure 5E–5H), which has not been reported before.